Patent · US Active

Compounds for the reduction of β-amyloid production

US8486952B2 · kind B2 · utility

30Cited by

2References

15Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Kenneth M. Boy · Durham, US
Jason M. Guernon · Hamden, US
John E. Macor · Guilford, US
Richard E. Olson · Wilmington, US
Jianliang Shi · Furlong, US
Lorin A. Thompson, III · Higganum, US
Yong-Jin Wu · Madison, US
Li Xu · Middletown, US
Yunhui Zhang · Glastonbury, US
Dmitry S. Zuev · Wallingford, US

Key dates

Filing date	Jul 28, 2010
Grant date	Jul 16, 2013
Priority date	—
Expiry date	Jan 1, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/113
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides a series of compounds of the formula (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.